Skip to main content

Advertisement

SpringerLink
Log in

Endocrine disruptors

The burden of endocrine-disrupting chemicals in the USA

  • News & Views
  • Published:

From Nature Reviews Endocrinology

View current issue Sign up to alerts

Endocrine-disrupting chemicals (EDCs) can contribute to the development of certain disorders and are known to have a high health-care burden in some countries. A new analysis has revealed the substantial impact of EDCs on health and associated costs in the USA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Attina, T. M. et al. Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis. Lancet Diabetes Endocrinol. http://dx.doi.org/10.1016/S2213-8587(16)30275-3 (2016).

  2. Trasande, L. et al. Estimating burden and disease costs of exposure to endocrine disrupting chemicals in the European Union. J. Clin. Endocrinol. Metab. 100, 1245–1255 (2015).

    Article  CAS  Google Scholar 

  3. Skakkebaek, N. E. et al. Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility. Physiol. Rev. 96, 55–97 (2016).

    Article  CAS  Google Scholar 

  4. Bergman, A., Heindel, J. J., Jobling, S., Kidd, K. A. & Zoeller, R. T. (eds) State of the Science of Endocrine Disrupting Chemicals — 2012 (WHO–UNEP, 2013).

    Google Scholar 

  5. Slama, R. et al. Scientific issues relevant to setting regulatory criteria to identify endocrine-disrupting substances in the European Union. Environ. Health Perspect. 124, 1497–1503 (2016).

    Article  Google Scholar 

  6. Jones, G., Garthwaite, D., Wynne, S. & Twining, G. Agronomic and economic impact assessment for possible human health and ecotoxicology criteria for endocrine disrupting chemicals. Report to Chemicals Regulation Directorate. FERA randd.defra.gov.uk/Document.aspx?Document=11346_PS2818finalreportfull.pdf (2013).

  7. Kristensen, D. et al. Analgesics use — prevalence, biomonitoring and endocrine and reproductive effects. Nat. Rev. Endocrinol. 12, 381–393 (2016).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Andreas Kortenkamp is at Brunel University London, Institute of Environment, Health and Societies, Kingston Lane, Uxbridge, Middlesex UB8 3PH, UK.,

    Andreas Kortenkamp

Authors
  1. Andreas Kortenkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andreas Kortenkamp.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kortenkamp, A. The burden of endocrine-disrupting chemicals in the USA. Nat Rev Endocrinol 13, 6–7 (2017). https://doi.org/10.1038/nrendo.2016.198

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2016.198

  • Springer Nature Limited

This article is cited by

Search

Navigation